Stock listing

Collegium Pharmaceutical, Inc.

Selected listing: COLL · NASDAQ · USD · US

Collegium Pharmaceutical, Inc. (NASDAQ:COLL), Health Technology. Latest release Aug 6, 2026: Collegium Reports Second Quarter 2026 Financial Results…

COLL:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:COLL
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. is a public company traded under the ticker COLL in the American market. Collegium focuses on developing and commercializing innovative products for the treatment of pain and other medical conditions.

Latest news from Collegium Pharmaceutical, Inc.

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

August 6, 2026

Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026

July 23, 2026

DivcoWest Welcomes Collegium Pharmaceutical to One Lincoln

July 20, 2026

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

July 20, 2026

Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 5, 2026

All Collegium Pharmaceutical, Inc. news →

Events

Replays

Collegium Pharmaceutical, Inc. (COLL) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 08:00 AM ET
Watch
Collegium Pharmaceutical, Inc. (COLL) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:00 AM ET
Watch
Collegium Pharmaceutical, Inc. (COLL) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:00 AM ET
Watch

Research Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. company profile

View the public company page for Collegium Pharmaceutical, Inc. on 6ix.

Collegium Pharmaceutical, Inc. news

Read company news and market updates connected to Collegium Pharmaceutical, Inc..

Collegium Pharmaceutical, Inc. investor events

Find investor webinars, events, and replay context for Collegium Pharmaceutical, Inc..